000 -LEADER |
fixed length control field |
01130nam a2200325 i 4500 |
001 - CONTROL NUMBER |
control field |
020128333 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
Uk |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20221214154837.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
210304s2022 ne a b 001|0|eng|d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780702081545 |
Qualifying information |
paperback |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Canceled/invalid ISBN |
9780702081569 (ePub ebook) |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
StDuBDS |
Language of cataloging |
eng |
Transcribing agency |
StDuBDS |
Description conventions |
rda |
Modifying agency |
MY-SjTCS |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 |
Item number |
AUL 2022 |
245 00 - TITLE STATEMENT |
Title |
Aulton's pharmaceutics : |
Remainder of title |
the design and manufacture of medicines. |
246 30 - VARYING FORM OF TITLE |
Title proper/short title |
Pharmaceutics |
250 ## - EDITION STATEMENT |
Edition statement |
Sixth edition / |
Remainder of edition statement |
edited by Kevin M.G. Taylor, Michael Aulton. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Amsterdam : |
Name of producer, publisher, distributor, manufacturer |
Elsevier, |
Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xx, 946 pages : |
Other physical details |
illustrations ; |
Dimensions |
24 cm |
336 ## - CONTENT TYPE |
Content type term |
text |
Source |
rdacontent |
336 ## - CONTENT TYPE |
Content type term |
still image |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Source |
rdacarrier |
500 ## - GENERAL NOTE |
General note |
Previous edition: Edinburgh: Elsevier, 2018. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Dosage forms |
9 (RLIN) |
21815 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Design |
9 (RLIN) |
21816 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Taylor, Kevin, |
Dates associated with a name |
1961- |
Relator term |
editor. |
9 (RLIN) |
51380 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Aulton, Michael E. |
Relator term |
editor. |
9 (RLIN) |
21817 |
920 ## - |
-- |
SOP : 333870, 333871 |